KERALA AYURVEDA
Back to Cashflow Statement
|
KERALA AYURVEDA Last 5 Year Cash Flow from Operating Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Operating Activities | ₹4.83 Cr | ₹2.03 Cr | ₹9.86 Cr | ₹-0.50 Cr | ₹7.43 Cr |
What is the latest Cash Flow from Operating Activities ratio of KERALA AYURVEDA ?
| Year | Cash Flow from Operating Activities |
|---|---|
| Mar2025 | ₹4.83 Cr |
| Mar2024 | ₹2.03 Cr |
| Mar2023 | ₹9.86 Cr |
| Mar2022 | ₹-0.50 Cr |
| Mar2021 | ₹7.43 Cr |
How is Cash Flow from Operating Activities of KERALA AYURVEDA Trending?
| Years | Cash Flow from Operating Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹4.83 Cr | 137.73 | |
| Mar2024 | ₹2.03 Cr | -79.38 | |
| Mar2023 | ₹9.86 Cr | Positive | |
| Mar2022 | ₹-0.50 Cr | Negative | |
| Mar2021 | ₹7.43 Cr | - | |
Compare Cash Flow from Operating Activities of peers of KERALA AYURVEDA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| KERALA AYURVEDA | ₹265.1 Cr | -9.3% | -15.8% | -47.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹457,121.0 Cr | 3.2% | 12.5% | 10.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹181,396.0 Cr | 2.9% | 8.5% | 11.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹148,730.0 Cr | 0.3% | 5.7% | 36.3% | Stock Analytics | |
| CIPLA | ₹115,241.0 Cr | 10.4% | 15.9% | -5.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹111,126.0 Cr | 4.8% | 9% | 10.8% | Stock Analytics | |
KERALA AYURVEDA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| KERALA AYURVEDA | -9.3% |
-15.8% |
-47.7% |
| SENSEX | -0.9% |
-3.6% |
-8.6% |
You may also like the below Video Courses